GENE ONLINE|News &
Opinion
Blog

PD-L1
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
BMS Enters Esophageal Cancer Therapy Area Amidst High Competition
2020-09-27
A New Imaging Tool Predicts Response of Cancer Patients to Immune Checkpoint Inhibition Therapy
2020-08-30
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
Keytruda Wins Big in China, Now Approved for Esophageal Squamous Cell Carcinomas
2020-06-26
ASCO 2020: Immunotherapy Gives Hope to Women with Placental Cancer
2020-06-01
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
CRISPR-Edited T cells Evaluated in Combating Lung Cancer
2020-05-10
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
Weekly in Asia|Oct-1
2019-10-14
Weekly in Asia 20190609-0615
2019-06-21
Erdafitinib Approval,a Bright Spot Amid the Troughs in Bladder Cancer Trials
2019-04-23
Next Gen IO update – early phase clinical trials of anti-TIGIT/LAG3 antibodies
2018-11-08
1 2
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top